Business Context and Reporting Period
This Form 8-K was filed by Sonus Pharmaceuticals, Inc. on November 21, 2006. The report discloses the entry into a material definitive agreement regarding the company's operational facilities.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate operational event rather than financial performance.
Material Changes
On November 21, 2006, Sonus Pharmaceuticals, Inc. entered into a lease agreement with BMR-217th Place, LLC. Key details include:
- New Location: 1522 217th Place SE, Bothell, Washington.
- Space: Approximately 38,000 square feet of office and laboratory space.
- Move: The company will relocate from its current address at 22026 20th Ave SE, Bothell, WA.
- Term: Ten years.
- Commencement: Scheduled for September 1, 2007, contingent upon the substantial completion of certain building improvements.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management commentary on future performance, or discussion of risks and contingencies beyond the operational move. The commencement of the lease is subject to the condition that building improvements are completed.
Investor Verification Checklist
- Verify the status of building improvements at 1522 217th Place SE to confirm the September 1, 2007, move-in date.
- Review the full lease agreement for details on rent, escalation clauses, and termination rights not summarized in this 8-K.
- Assess the capital expenditure required for the relocation and fit-out of the new 38,000 square foot facility.